Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

BACKGROUND: In breast cancer patients routine thromboprophylaxis is not recommended but individualized risk assessment is encouraged. The incorporation of hypercoagulability biomarkers could increase the sensitivity of risk assessment models (RAM) to identify patients at VTE risk. To this aim we inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaari, Mourad, Ayadi, Ines, Rousseau, Aurelie, Lefkou, Eleftheria, Van Dreden, Patrick, Sidibe, Fatoumata, Ketatni, Hela, Galea, Vassiliki, Khaterchi, Amir, Bouzguenda, Racem, Frikha, Mounir, Ghorbal, Lilia, Daoud, Jamel, Kallel, Choumous, Quinn, Martin, Gligorov, Joseph, Lotz, Jean Pierre, Hatmi, Mohamed, Elalamy, Ismail, Gerotziafas, Grigoris T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324665/
https://www.ncbi.nlm.nih.gov/pubmed/25535397
http://dx.doi.org/10.1186/1471-2407-14-991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324665/
https://www.ncbi.nlm.nih.gov/pubmed/25535397
http://dx.doi.org/10.1186/1471-2407-14-991

Ejemplares similares